Loading...

Ipsen S.A.

IPSEYPNK
HealthcareDrug Manufacturers - Specialty & Generic
$29.50
$-0.61(-2.03%)

Ipsen S.A. IPSEY Peers

See (IPSEY) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
IPSEY$29.50-2.03%39B24.38$1.21N/A
CHALF$0.38+37999900.00%441.8B-4.75-$0.08N/A
STMH$0.10+99900.00%125.8B-0.05-$1.89N/A
THCBF$0.02+2350.00%58.1B-2.45-$0.01N/A
MKKGY$26.26-0.30%56.9B17.99$1.46+2.17%
MKGAF$128.36-4.25%55.8B17.63$7.28+1.72%
HLNCF$5.49+1.01%49.5B26.12$0.21+1.98%
TKPHF$28.03+6.58%44.1B60.93$0.46+4.75%
KHRNF$0.01+79900.00%41.8B-0.80-$0.01N/A
EVRRF$0.07+2780.00%25.6B-2.40-$0.03N/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

IPSEY vs CHALF Comparison

IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IPSEY stands at 39B. In comparison, CHALF has a market cap of 441.8B. Regarding current trading prices, IPSEY is priced at $29.50, while CHALF trades at $0.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IPSEY currently has a P/E ratio of 24.38, whereas CHALF's P/E ratio is -4.75. In terms of profitability, IPSEY's ROE is +0.17%, compared to CHALF's ROE of +0.00%. Regarding short-term risk, IPSEY is less volatile compared to CHALF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.

Stock Price Comparison

Loading...

Frequently Asked Questions